ATHIRA PHARMA INC (ATHA) Stock Income Statement
USA - NASDAQ:ATHA - US04746L1044 - Common Stock
4.21 USD
+0.35 (+9.07%)
4 USD
-0.21 (-4.99%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 57.89M | 96.78M | 127.09M | 94.02M | 64.02M | |||
| Research and Development | 35.26M | 70.68M | 93.79M | 61.46M | 42.79M | |||
| Selling, General, and Administrative Expenses | 22.63M | 26.09M | 33.30M | 32.55M | 21.23M | |||
| Operating Income | -57.89M | -96.78M | -127.09M | -94.02M | -64.02M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | 330.00K | |||
| Other Income/Expense | 2.16M | 3.96M | 7.79M | 8.38M | 8.84M | |||
| Non Recurring Items | N/A | -4.13M | 1.63M | -10.00M | 0.00 | |||
| Income Before Taxes | -59.85M | -96.94M | -117.67M | -95.64M | -54.85M | |||
| Net Income | -59.85M | -96.94M | -117.67M | -95.64M | -54.85M | |||
| EBITDA | -56.91M | -95.81M | -126.13M | -93.17M | -63.54M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.55 | -2.52 | -3.10 | -2.53 | -1.49 | |||
| Non GAAP EPS | -1.55 | -2.53 | -3.09 | -2.27 | -1.50 | |||
| Statistics | ||||||||
All data in USD